| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.03 |